| 1 Tag | +1.70% |
| Manager | Titel | Alter | Seit |
|---|---|---|---|
Marc Dunoyer
CEO | Vorstandsvorsitzender | 73 | - |
Sean Christie
DFI | Finanzdirektor/CFO | 53 | 01.08.2021 |
Doyle Shane
COO | Geschäftsführer | - | - |
| Datum | Initiiert | Typ | Hauptposition | Anzahl | % Marktkap. | |
|---|---|---|---|---|---|---|
| 21.07.21 | Emittentenverkauf | Chief Operating Officer (COO) | 172’582 | 0.0781% | ||
| 21.07.21 | Emittentenverkauf | Director | 28’216 | 0.0128% | ||
| 21.07.21 | Emittentenverkauf | Chief Financial Officer (CFO) | 120’253 | 0.0544% |
| % | % 5 Tage | % 1 Jahr | Veränd. 3 Jahre | Kap.($) | ||
|---|---|---|---|---|---|---|
| +1.70% | -2.20% | - | - | 40.34 Mrd. | ||
| -0.53% | -3.95% | +55.23% | +152.74% | 1’024 Mrd. | ||
| +0.21% | -2.68% | +55.61% | +53.02% | 618 Mrd. | ||
| -2.51% | -3.25% | +32.76% | +67.76% | 443 Mrd. | ||
| +0.06% | -0.42% | +37.53% | +30.67% | 349 Mrd. | ||
| -0.14% | -0.24% | +34.41% | +39.01% | 297 Mrd. | ||
| -0.69% | -0.30% | +11.55% | +12.93% | 264 Mrd. | ||
| -7.37% | -4.40% | -2.54% | -43.87% | 209 Mrd. | ||
| -0.64% | +2.43% | +30.52% | +64.49% | 208 Mrd. | ||
| -0.82% | +0.70% | +15.96% | +71.01% | 162 Mrd. | ||
| Durchschnitt | -1.07% | -1.20% | +30.11% | +49.75% | 397.08 Mrd. | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | -0.96% | -1.93% | +39.24% | +72.95% |
Beschäftigte
3’837
Sektor
Pharmazeutika
















